Quote data as of 6:12 AM ET
LifeMD, Inc. functions as a direct-to-patient telehealth enterprise, linking individuals with healthcare professionals throughout the United States for a diverse array of medical concerns. These services encompass everything from personalized concierge care to specialized fields such as men's sexual health and dermatology. The company operates a portfolio of distinct telehealth brands. ShapiroMD is dedicated to comprehensive hair loss solutions, offering virtual consultations, prescription medications, unique over-the-counter products, an FDA-approved medical device, and specialized compounded topical treatments for both male and female hair loss. RexMD provides virtual medical treatment from licensed providers for various men's health requirements. LifeMD Primary Care is a subscription-based, mobile-first platform delivering personalized virtual primary, urgent, and chronic care, integrating online consultations, prescription services, diagnostics, and imaging. Cleared focuses on customized treatments for allergy, asthma, and immunological conditions. Nava MD serves as a female-oriented tele-dermatology and skincare brand, facilitating virtual medical consultations with dermatologists and other experts. Beyond its healthcare focus, LifeMD also manages PDFSimpli, an online software-as-a-service (SaaS) platform that empowers users to create, edit, convert, sign, and share PDF documents. The company distributes its products and services directly to consumers, through e-commerce channels, and via third-party partner networks. Initially established in 1994 as Conversion Labs, Inc., the company officially rebranded to LifeMD, Inc. in February 2021. Its corporate headquarters are located in New York, New York.
LifeMD entered an exclusive co-marketing collaboration with Halozyme’s Antares Pharma to launch a direct-to-patient self-pay program for XYOSTED, the only FDA-approved once-weekly subcutaneous testosterone auto-injector.
The program is set to launch in July 2026 across 37 states, offering the treatment at a transparent all-inclusive price of approximately $249 per month that covers both medication and clinical care.
LifeMD will serve as the exclusive telehealth partner, utilizing its affiliated medical group for evaluations and its pharmacy for direct-to-home dispensing, addressing barriers to access for testosterone deficiency treatment.